Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of a Juvenile Arthritis Support Program (JASP-1) for Children Recently Diagnosed With Juvenile Idiopathic Arthritis (JIA) and Their Parents

NCT06284616 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06284616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06284616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of a Juvenile Arthritis Support Program (JASP-1) for Children Recently Diagnosed With Juvenile Idiopathic Arthritis (JIA) and Their Parents
Lead sponsor
Region Stockholm
Phase
Not applicable
Overall status
Completed
Start date
August 15, 2019
Completion date
December 31, 2023
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

jia, patient outcome assessment, patient satisfaction, support program